Skip to main content
Erschienen in: Pediatric Nephrology 9/2010

01.09.2010 | Educational Review

The “other” vasculitis syndromes and kidney involvement

verfasst von: Seza Ozen

Erschienen in: Pediatric Nephrology | Ausgabe 9/2010

Einloggen, um Zugang zu erhalten

Abstract

There are a number of vasculitides that are not confined to a specific vessel size, do not have characteristic features, and/or are not secondary to another disease. Most of these vasculitides are rare in childhood. Behçet disease is representative of this group as it involves vessels of any size on both the arterial and venous side. In addition to renal vascular involvement, Behçet disease may involve the kidney through glomerulonephritis, secondary amyloidosis and, rarely, tubulointerstital involvement. Vasculitis secondary to infections, malignancy, and drugs are not common among children. However, vasculitis may be associated with a number of rheumatic diseases in childhood and the auto-inflammatory syndromes (periodic fever syndromes). Auto-inflammatory syndromes are diseases characterized by periodic attacks of clinical and laboratory inflammation. Studies carried out during the past decade have provided valuable information on the mechanism of inflammation and innate immunity in general. This group of vasculitides is associated with secondary amyloidosis of the kidney if not treated. Hypocomplementemic urticarial vasculitis is an interesting vasculitic disease with frequent kidney involvement. Here, we introduce the reader to the wide scope of these diseases; although rare, such diseases represent a challenge to the nephrologist.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McClusky RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192CrossRefPubMed Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McClusky RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192CrossRefPubMed
2.
Zurück zum Zitat Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941CrossRefPubMed Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941CrossRefPubMed
3.
Zurück zum Zitat Gluth MB, Baratz KH, Matteson EL, Driscoll CL (2006) Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 81:483–488CrossRefPubMed Gluth MB, Baratz KH, Matteson EL, Driscoll CL (2006) Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 81:483–488CrossRefPubMed
4.
5.
6.
Zurück zum Zitat Ozen S, Petty RE (2005) Behçet Disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 561–567 Ozen S, Petty RE (2005) Behçet Disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 561–567
7.
Zurück zum Zitat Mahr A, Belarbi L, Wechsler B, Jeannneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L (2008) Population based prevalence study of BD: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 58:3951–3959CrossRefPubMed Mahr A, Belarbi L, Wechsler B, Jeannneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L (2008) Population based prevalence study of BD: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 58:3951–3959CrossRefPubMed
8.
Zurück zum Zitat The International Study Group for Behçet's disease (1992) Evaluation of diagnostic ('classification') criteria in Behçet's disease—towards internationally agreed criteria. Br J Rheumatol 31:299–308CrossRef The International Study Group for Behçet's disease (1992) Evaluation of diagnostic ('classification') criteria in Behçet's disease—towards internationally agreed criteria. Br J Rheumatol 31:299–308CrossRef
9.
Zurück zum Zitat Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S (2002) Renal Behçet's disease: a cumulative analysis. Semin Arthritis Rheum 31:317–337CrossRefPubMed Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S (2002) Renal Behçet's disease: a cumulative analysis. Semin Arthritis Rheum 31:317–337CrossRefPubMed
10.
Zurück zum Zitat Akutsu Y, Itami N, Tanaka M, Kusunoki Y, Tochiaru H, Takekoshi Y (1990) IgA nephritis in BD: case report and review of literature. Clin Nephrol 34:52–55PubMed Akutsu Y, Itami N, Tanaka M, Kusunoki Y, Tochiaru H, Takekoshi Y (1990) IgA nephritis in BD: case report and review of literature. Clin Nephrol 34:52–55PubMed
11.
Zurück zum Zitat Sakemi T, Yoshiyuki T, Ikeda Y, Suzuki N, Nagasawa K (1998) End stage renal failure due to crescentic GN in a patient with Behçet syndrome. Review of literature. Am J Nephrol 18:321–324CrossRefPubMed Sakemi T, Yoshiyuki T, Ikeda Y, Suzuki N, Nagasawa K (1998) End stage renal failure due to crescentic GN in a patient with Behçet syndrome. Review of literature. Am J Nephrol 18:321–324CrossRefPubMed
12.
Zurück zum Zitat Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H, EULAR Expert Committee (2008) EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 67:1656–1662CrossRefPubMed Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H, EULAR Expert Committee (2008) EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 67:1656–1662CrossRefPubMed
13.
Zurück zum Zitat Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Pariès J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Blétry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 57(8):1473–1480CrossRefPubMed Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Pariès J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Blétry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 57(8):1473–1480CrossRefPubMed
14.
Zurück zum Zitat Wiik A (2005) Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther 7(5):191–192CrossRefPubMed Wiik A (2005) Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther 7(5):191–192CrossRefPubMed
15.
Zurück zum Zitat Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P, French Vasculitis Study Group (2005) Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84:313–322CrossRef Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P, French Vasculitis Study Group (2005) Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84:313–322CrossRef
16.
Zurück zum Zitat Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, García-Consuegra J, Dolezalova P, Dressler F, Duzova A, Ferriani VP, Hilário MO, Ibáñez-Rubio M, Kasapcopur O, Kuis W, Lehman TJ, Nemcova D, Nielsen S, Oliveira SK, Schikler K, Sztajnbok F, Terreri MT, Zulian F, Woo P (2004) Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145:517–522CrossRefPubMed Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, García-Consuegra J, Dolezalova P, Dressler F, Duzova A, Ferriani VP, Hilário MO, Ibáñez-Rubio M, Kasapcopur O, Kuis W, Lehman TJ, Nemcova D, Nielsen S, Oliveira SK, Schikler K, Sztajnbok F, Terreri MT, Zulian F, Woo P (2004) Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145:517–522CrossRefPubMed
17.
Zurück zum Zitat Duzova A, Bakkaloglu A, Yuce A, Ozen S, Koçak N (2001) Successful treatment of polyarteritis nodosa with interferon alpha in a nine-month old girl. Eur J Pediatr 160:519–520CrossRefPubMed Duzova A, Bakkaloglu A, Yuce A, Ozen S, Koçak N (2001) Successful treatment of polyarteritis nodosa with interferon alpha in a nine-month old girl. Eur J Pediatr 160:519–520CrossRefPubMed
18.
Zurück zum Zitat Gao Y, Zhao MH (2009) Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 14:33–41CrossRef Gao Y, Zhao MH (2009) Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 14:33–41CrossRef
19.
Zurück zum Zitat Silverman ED, Hebert D (2004) Paediatric systemic lupus erythematosus. In: Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld FC (eds) Oxford textbook of rheumatology, 3rd edn. Oxford University Press, Oxford, pp 848–862 Silverman ED, Hebert D (2004) Paediatric systemic lupus erythematosus. In: Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld FC (eds) Oxford textbook of rheumatology, 3rd edn. Oxford University Press, Oxford, pp 848–862
20.
Zurück zum Zitat Hamasaki K, Mimura T, Kanda H, Kubo K, Setoguchi K, Satoh T, Misaki Y, Yamamoto K (2003) Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 22:355–358CrossRefPubMed Hamasaki K, Mimura T, Kanda H, Kubo K, Setoguchi K, Satoh T, Misaki Y, Yamamoto K (2003) Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 22:355–358CrossRefPubMed
21.
Zurück zum Zitat Stojanov S, Kastner DL (2005) Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 17:586–599CrossRefPubMed Stojanov S, Kastner DL (2005) Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 17:586–599CrossRefPubMed
22.
Zurück zum Zitat Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117CrossRefPubMed Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117CrossRefPubMed
23.
Zurück zum Zitat Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, Gumucio DL, Shoham NG, Kastner DL (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 112:1794–1803CrossRefPubMed Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, Gumucio DL, Shoham NG, Kastner DL (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 112:1794–1803CrossRefPubMed
24.
Zurück zum Zitat Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of FMF. Arthritis Rheum 40:1879–1885CrossRefPubMed Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of FMF. Arthritis Rheum 40:1879–1885CrossRefPubMed
25.
Zurück zum Zitat Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, Kasapçopur O, Elhan AH, Doganay B, Ekim M, Kara N, Uncu N, Bakkaloglu A (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 48:395–398CrossRefPubMed Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, Kasapçopur O, Elhan AH, Doganay B, Ekim M, Kara N, Uncu N, Bakkaloglu A (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 48:395–398CrossRefPubMed
26.
Zurück zum Zitat Lachmann HJ, Sengül B, Yavuzşen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soytürk M, Akar S, Tunca M, Hawkins PN (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45:746–750CrossRef Lachmann HJ, Sengül B, Yavuzşen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soytürk M, Akar S, Tunca M, Hawkins PN (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45:746–750CrossRef
27.
Zurück zum Zitat Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30:2014–2018PubMed Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30:2014–2018PubMed
28.
29.
Zurück zum Zitat Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26:612–627CrossRefPubMed Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26:612–627CrossRefPubMed
30.
Zurück zum Zitat Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623CrossRefPubMed Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623CrossRefPubMed
31.
Zurück zum Zitat Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arizi M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E; Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11CrossRefPubMed Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arizi M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E; Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11CrossRefPubMed
32.
Zurück zum Zitat Gershoni-Baruch R, Broza Y, Brik R (2003) Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr 143:658–661CrossRefPubMed Gershoni-Baruch R, Broza Y, Brik R (2003) Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr 143:658–661CrossRefPubMed
33.
Zurück zum Zitat Yalçinkaya F, Ozçakar ZB, Kasapçopur O, Oztürk A, Akar N, Arisoy N, Ozen S (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678CrossRefPubMed Yalçinkaya F, Ozçakar ZB, Kasapçopur O, Oztürk A, Akar N, Arisoy N, Ozen S (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678CrossRefPubMed
34.
Zurück zum Zitat Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, Turgan C, Turkmen A, Akpolat I, Danaci M, Besbas N, Akpolat T (2001) Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): aconcomitant disease or a feature of FMF? Semin Arthritis Rheum 30:281–287CrossRefPubMed Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, Turgan C, Turkmen A, Akpolat I, Danaci M, Besbas N, Akpolat T (2001) Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): aconcomitant disease or a feature of FMF? Semin Arthritis Rheum 30:281–287CrossRefPubMed
35.
Zurück zum Zitat Ozen S (2009) Mutations/Polymorphisms in a monogenic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol (in press) Ozen S (2009) Mutations/Polymorphisms in a monogenic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol (in press)
36.
Zurück zum Zitat Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368CrossRef Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368CrossRef
37.
Zurück zum Zitat Nedjai B, Hitman GA, Quillinan N, Coughlan RJ, Church L, McDermott MF, Turner MD (2009) Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 60:619–625CrossRefPubMed Nedjai B, Hitman GA, Quillinan N, Coughlan RJ, Church L, McDermott MF, Turner MD (2009) Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 60:619–625CrossRefPubMed
38.
Zurück zum Zitat Frenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M, Kuijpers TW, van Luijk W, Poll-The BT, Kuis W (2001) Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatology 40:579–584CrossRefPubMed Frenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M, Kuijpers TW, van Luijk W, Poll-The BT, Kuis W (2001) Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatology 40:579–584CrossRefPubMed
39.
Zurück zum Zitat Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 63:260–264PubMed Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 63:260–264PubMed
40.
Zurück zum Zitat Tsimaratos M, Kone-Paut I, Daniel L, Gubler MC, Dussol B, Picon G (1999) Crescentic GN in hyper IgD syndrome. Pediatr Nephrol 13:132–134CrossRefPubMed Tsimaratos M, Kone-Paut I, Daniel L, Gubler MC, Dussol B, Picon G (1999) Crescentic GN in hyper IgD syndrome. Pediatr Nephrol 13:132–134CrossRefPubMed
41.
Zurück zum Zitat Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607–612CrossRefPubMed Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607–612CrossRefPubMed
42.
Zurück zum Zitat Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, Anderson JP, Wanderer AA, Firestein GS (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364:1779–1785CrossRefPubMed Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, Anderson JP, Wanderer AA, Firestein GS (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364:1779–1785CrossRefPubMed
43.
Zurück zum Zitat Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, Derfalvi B, Benjaponpitak S, Vesely R, Sauvain MJ, Oertle S, Allen R, Morgan G, Borkhardt A, Hill C, Gardner-Medwin J, Fischer A, de Saint Basile G (2004) Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 103:2809–2815CrossRefPubMed Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, Derfalvi B, Benjaponpitak S, Vesely R, Sauvain MJ, Oertle S, Allen R, Morgan G, Borkhardt A, Hill C, Gardner-Medwin J, Fischer A, de Saint Basile G (2004) Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 103:2809–2815CrossRefPubMed
44.
Zurück zum Zitat Balsam L, Karim M, Miller F, Rubinstein S (2008) Crescentic glomerulonephritis associated with hypocomplementemic urticarial vasculitis syndrome. Am J Kidney Dis 52:1168–1173CrossRefPubMed Balsam L, Karim M, Miller F, Rubinstein S (2008) Crescentic glomerulonephritis associated with hypocomplementemic urticarial vasculitis syndrome. Am J Kidney Dis 52:1168–1173CrossRefPubMed
45.
Zurück zum Zitat Schwartz HR, McDuffie FC, Black LF, Schroeter AL, Conn DL (1982) Hypocomplementemic urticarial vasculitis. Mayo Clin Proc 57:231–238PubMed Schwartz HR, McDuffie FC, Black LF, Schroeter AL, Conn DL (1982) Hypocomplementemic urticarial vasculitis. Mayo Clin Proc 57:231–238PubMed
46.
Zurück zum Zitat Agnello V, Koffler D, Eisenberg JW, Winchester RJ, Kundel HG (1971) C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 134:228PubMed Agnello V, Koffler D, Eisenberg JW, Winchester RJ, Kundel HG (1971) C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 134:228PubMed
Metadaten
Titel
The “other” vasculitis syndromes and kidney involvement
verfasst von
Seza Ozen
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 9/2010
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-009-1327-2

Weitere Artikel der Ausgabe 9/2010

Pediatric Nephrology 9/2010 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.